Skip to Main Content
Experimental Futures

Asian Biotech: Ethics and Communities of Fate

Edited by
Aihwa Ong
Aihwa Ong

Aihwa Ong is Professor of Anthropology at the University of California, Berkeley. She is the author of Neoliberalism as Exception: Mutations in Citizenship and Sovereignty and Flexible Citizenship: The Cultural Logics of Transnationality, both also published by Duke University Press.

Nancy N. Chen is Professor of Anthropology at Scripps College. She is the author of Food, Medicine, and the Quest for Good Health and Breathing Spaces: Qigong, Psychiatry, and Healing in China.

Search for other works by this author on:
Nancy N. Chen
Nancy N. Chen

Aihwa Ong is Professor of Anthropology at the University of California, Berkeley. She is the author of Neoliberalism as Exception: Mutations in Citizenship and Sovereignty and Flexible Citizenship: The Cultural Logics of Transnationality, both also published by Duke University Press.

Nancy N. Chen is Professor of Anthropology at Scripps College. She is the author of Food, Medicine, and the Quest for Good Health and Breathing Spaces: Qigong, Psychiatry, and Healing in China.

Search for other works by this author on:
Duke University Press
ISBN electronic:
978-0-8223-9320-7
Publication date:
2010

Providing the first overview of Asia’s emerging biosciences landscape, this timely and important collection brings together ethnographic case studies on biotech endeavors such as genetically modified foods in China, clinical trials in India, blood collection in Singapore and China, and stem-cell research in Singapore, South Korea, and Taiwan. While biotech policies and projects vary by country, the contributors identify a significant trend toward state entrepreneurialism in biotechnology, and they highlight the ways that political thinking and ethical reasoning are converging around the biosciences. As ascendant nations in a region of postcolonial emergence, with an “uncanny surplus” in population and pandemics, Asian countries treat their populations as sources of opportunity and risk. Biotech enterprises are allied to efforts to overcome past humiliations and restore national identity and political ambition, and they are legitimized as solutions to national anxieties about food supplies, diseases, epidemics, and unknown biological crises in the future. Biotechnological responses to perceived risks stir deep feelings about shared fate, and they crystallize new ethical configurations, often re-inscribing traditional beliefs about ethnicity, nation, and race. As many of the essays in this collection illustrate, state involvement in biotech initiatives is driving the emergence of “biosovereignty,” an increasing pressure for state control over biological resources, commercial health products, corporate behavior, and genetic based-identities. Asian Biotech offers much-needed analysis of the interplay among biotechnologies, economic growth, biosecurity, and ethical practices in Asia.

Contributors

Vincanne Adams

Nancy N. Chen

Stefan Ecks

Kathleen Erwin

Phuoc V. Le

Jennifer Liu

Aihwa Ong

Margaret Sleeboom-Faulkner

Kaushik Sunder Rajan

Wen-Ching Sung

Charis Thompson

Ara Wilson

Table of Contents

Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal